skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

疫学予測、プライマリー調査による医療用医薬品の市場調査レポートライブラリー

Datamonitor Healthcare

Datamonitor Healthcare(データモニターヘルスケア)では、欧米に拠点を置くインフォーマのアナリストによる医療用医薬品の市場調査レポートを収録しています。各市場調査レポートは米国、欧州5か国(イギリス、フランス、ドイツ、イタリア、スペイン)、日本の計7つの医薬品市場を中心に、各疾患市場について下記の項目を網羅しています。疫学情報、治療実態、売上予測に関してはエクセルファイルでデータパックのダウンロードも可能です。

  • 薬剤の売上予測(患者数ベース)
  • 各市場の疾患別治療実態
  • 疫学情報(アナリストとは異なる専門の疫学者(エピデミオロジスト(チームが担当。米国、欧州5か国、日本に加えその他38か国が対象)
  • 臨床および商業的観点からの上市済み医薬品と開発パイプラインの製品評価
  • 価格・償還制度

 

Datamonitor Healthcareでは下記項目を分析して患者ベースの売上予測を算出します。

  • 疫学者(エピデミオロジスト)チームによる患者セグメントの特定
  • 1疾患当たり7か国210名以上の専門医へのプライマリーリサーチ(アンケート調査によるKOLインタビュー)により治療アルゴリズムを特定
  • インフォーマのアナリストの見解を提示
    • 企業(財務、薬剤評価・比較、SWOT分析、成功確率に影響を与えるイベント分析)
    • 価格・償還(薬価下げ圧力、後発医薬品参入の影響)
    • 戦略(ヘルスケア業界全体のトレンド、医薬品市場の現状と課題)

     

Datamonitor Healthcareの活用事例などさらに詳しい説明を兼ねたデモンストレーションをご希望の場合は下記よりお申し込み下さい。

また、開発中の医療用医薬品の承認に影響を与えるイベントをリアルタイムで追跡し、アメリカ食品医薬品局(FDA)の承認確率(LOA: Likelihood of Approval)で示す姉妹サービスBiomedtracker(バイオメドトラッカー)を合わせて利用されるとより効果的です。

その他ご質問などございましたらお問い合わせフォームよりお気軽にご連絡ください。

このサービスの特徴

無料の最新記事&レポート

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Insight into NASH Pricing Strategies

    By Hannah Cohen 21 Oct 2019

    Explore the key hurdles to anticipating the initial and potential value of the NASH therapy market.

    Topic drug-approval business-strategies

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Providing Coverage of the Commercial Topics in Q3

    10 Oct 2019

    Providing Coverage of the Commercial Topics in Q3

    The Commercial Solutions Strategy Suite from Informa Pharma Intelligence unites the power of vital tools to bring you actionable data, penetrating analysis, and a crucial industry view covering a variety of critical market aspects, allowing you to accurately Forecast, Analyze and Benchmark, and Understand the mark landscape.   

    Topic drug-approval drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...

    Key potential drug launches 2020

    27 Sep 2019

    Take a longer-term look at key late-stage drugs projected to hit the market in 2020, including new drug classes, major changes to standards of care, and/or large market opportunities across the wide range of indications covered by Biomedtracker and Datamonitor Healthcare.

    Topic drug-approval drug-review drug-development-landscape

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Webinar: Manufacturing Challenges Facing Cell and Gene Therapy

    27 Sep 2019

    As more regenerative medicine products approach clinical testing and commercialization, seize this opportunity to hear detailed insights and industry best practices from preeminent sector experts. You’ll gain a deep understanding of numerous nurdles unique to bringing durable, curative therapies to patients in need.

    Topic cell-and-gene-therapy

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Reimbursement and Payer Management of Immune Checkpoint Inhibitors

    03 Sep 2019

    As immune checkpoint inhibitors continue to gain approvals in expanded patient populations, payers express concern surrounding the potential budget impact of the drug class. Considering the high costs of these treatments in comparison to standard chemotherapy, HTA and reimbursement agencies stress the requirement for solid survival data and highlight that price will be a major factor during negotiations

    Topic drug-review

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    NASH Disease Coverage Extract

    16 Aug 2019

    Datamonitor Healthcare recently surveyed 60 gastroenterologists in the US and five major EU markets after the approval of the first disease-specific therapies for the treatment of non-alcoholic steatohepatitis (NASH). The market for these treatments will exceed $21bn in 2027.   

    Topic Drug development landscape Diseases

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    2019 Q3 Outlook Webinar

    15 Jul 2019

    Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

    Topic immuno-oncology Infectious diseases

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    2018年ベストセラー医薬品トップ10

    15 Jul 2019

    無料ホワイトペーパー『2018年ベストセラー薬トップ10/原題:Top 10 Best-Selling Drugs of 2018 Fund US and EU Pharma R&D(全24頁)』では、2018年(17年10月~18年9月)にグローバルで最も多くの売上を上げた医薬品トップ10に共通する要因や今後の課題について分析しています。

    Topic drug-review strategy deal-trends

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Understand Market Access Trends in the US, Europe and Emerging Markets

    03 Jul 2019

    This essential whitepaper looks at how increased drug spending and a rising desire for expenditure controls are influencing access dynamics across key markets. It is available to you now, for free.

    Topic drug-development-landscape drug-approval drug-review

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

    By Michael ​ Haydock 02 Jul 2019

    Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

    Topic drug-approval drug-development-landscape drug-review

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Depression Disease Market and Forecast Analysis 2024

    15 Jun 2019

    Informa Pharma Intelligence is marking Depression Awareness Month with a free download of Depression Disease Market and Forecast Analysis 2024. Download your free extract from this vital report and tap into the exclusive data and insights into the depression market available only from the experts at Datamonitor Healthcare, part of the Informa Pharma Intelligence suite of tools.

    Topic drug-development-landscape

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Better Heart Health Whitepaper

    15 Jun 2019

    In recognition of World Heart Day, September 29, 2018, Informa Pharma Intelligence would like to invite you to download our latest whitepaper, Better Heart Health with Mobile Apps? The Impact of Mobile Apps on Coronary Heart Disease in the US. This exploration into the results of a recent analysis of the US Behavioral Risk Factor Surveillance System (BRFSS), coupled with an analysis of several health apps targeting coronary heart disease (CHD) and other heart disease factors, is available to you now – for free.

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Multiple Myeloma Pricing, Reimbursement, and Access

    13 Jun 2019

    Disease management and treatment programmes change, as research evolves and new discoveries are made. Your market access strategies must evolve too.

    Topic cancer drug-development-landscape reimbursement

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    World AIDS Day 2018 GlaxoSmithKline report

    11 Jun 2019

    PharmaVitae explores GlaxoSmithKline’s prescription pharmaceutical performance and outlook over 2017–27. PharmaVitae analyses include quarterly earnings coverage and provide timely updates to company product forecasts. The full company profile encompasses analysis on corporate strategy, portfolio analysis, pipeline potential, and financial performance.

    Topic Diseases Drug development landscape Drug review

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート

    Global Market Access Webinar

    By Louisa Joseph 13 May 2019

    Join subject-matter experts from Datamonitor Healthcare as they use data and their industry experience to examine the challenges and opportunities brought about by recent global trends in market access. Learn how to navigate this complex terrain, as increasingly restrictive pricing and reimbursement policies are having an adverse effect on sales of launched and pipeline products across many global markets.

    Topic reimbursement

医薬品産業専門のジャーナリスト&アナリスト

製品説明を兼ねた無料デモ&お問い合わせ

専任スタッフによる詳しい説明を兼ねた無料デモンストレーションを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。